Transient HIV-specific T cells increase and inflammation in an HIV-infected patient treated with nivolumab-Reference-Cited by-同舟云学术

Transient HIV-specific T cells increase and inflammation in an HIV-infected patient treated with nivolumab

Published:2017-04-24 Issue:7 Volume:31 Page:1048-1051
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Le Garff Gwenaëlle,Samri Assia,Lambert-Niclot Sidonie,Even Sophie,Lavolé Armelle,Cadranel Jacques,Spano Jean-Philippe,Autran Brigitte,Marcelin Anne-Geneviève,Guihot Amélie

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference15 articles.

1. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer;Borghaei;N Engl J Med,2015

2. Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer;Brahmer;N Engl J Med,2015

3. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced nonsmall-cell lung cancer (KEYNOTE-010): a randomised controlled trial;Herbst;Lancet,2016

4. Biological follow-up of patients with HIV treated with anti-PD-1 or anti-PD-L1 for nonsmall cell bronchial carcinoma: a task group proposal;Guihot;Rev Mal Respir,2016

5. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression;Day;Nature,2006

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune checkpoint inhibitors in infectious disease;Immunological Reviews;2024-09-09

2. HIV Persistence, Latency, and Cure Approaches: Where Are We Now?;Viruses;2024-07-19

3. Immune checkpoint inhibitors as potential therapy for reverting T-cell exhaustion and reverting HIV latency in people living with HIV;Frontiers in Immunology;2023-12-07

4. Clinical trials aimed at HIV cure or remission: new pathways and lessons learned;Expert Review of Anti-infective Therapy;2023-10-24

5. Selective loss of CD107a TIGIT+ memory HIV-1-specific CD8+ T cells in PLWH over a decade of ART;eLife;2023-09-19